Goldman Sachs maintains Rocket Lab USA stock rating, citing Neutron delays

Published 13/11/2025, 10:52
Goldman Sachs maintains Rocket Lab USA stock rating, citing Neutron delays

Investing.com - Goldman Sachs has reiterated its Neutral rating and $47.00 price target on Rocket Lab USA (NASDAQ:RKLB) following the company’s third-quarter 2025 financial results. Currently trading at $49.97, RKLB has surged 165% over the past year despite recent pullbacks, according to InvestingPro data.

The space launch provider reported revenue and earnings per share that exceeded consensus expectations for the quarter, though adjusted EBITDA fell short of analyst forecasts. RKLB posted $554.53 million in revenue over the last twelve months, representing impressive 52.42% growth.

Rocket Lab announced a delay in the inaugural launch of its Neutron rocket to the first quarter of 2026, with plans to conduct three additional full-price launches within 12 months of the initial launch.

Despite a sequential decline in Electron launches during the quarter, the company reported accelerating demand with a record backlog of 49 launches, indicating strong future revenue potential.

The company’s Space Systems division demonstrated continued momentum, maintaining its backlog while delivering strong growth, though Goldman Sachs noted that risks associated with the upcoming Neutron launch remain difficult to evaluate.

In other recent news, Rocket Lab USA has reported significant developments in its financial performance and business strategy. The company posted third-quarter revenue of $155.1 million, which marks a 48% increase year-over-year and surpasses the consensus estimate of $151.9 million. However, Rocket Lab also reported an adjusted EBITDA loss of $26.3 million, which was greater than the anticipated $22.0 million loss. Analysts have responded to these results with various adjustments to their price targets and ratings. Needham raised its price target to $63, citing strong revenue growth and improved gross margins. Roth/MKM and KeyBanc both increased their price targets to $75, highlighting the company’s margin strength and growing backlog. Cantor Fitzgerald also increased its price target to $72, emphasizing the potential impact of Rocket Lab’s upcoming Neutron launch vehicle. Meanwhile, Citizens maintained a Market Perform rating, reflecting the mixed nature of the quarterly results. These developments indicate a cautious optimism among analysts regarding Rocket Lab’s future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.